Treatment of feline leukemia virus (FeLV) infection.

Abstract

FeLV infection is still considered to account for most disease-related deaths in pet cats. Different treatment attempts with various drugs were performed in the past but none resulted in healing or complete virus elimination. Therefore, it caused a sensation when Horber and Mayr [Horber, D., Mayr, B., 1991. Prax. 19, 311-314; Horber, D., Schnabl, W., Mayr, B., 1992. Tierarztl. Umschau 47, 556-560; Mayr, B., Horber, D., 1992. Kleintierprax. 37, 515-518] published that they were able to cure 80 to 100% FeLV-infected cats from viremia by using an immunomodulating compound. Articles in cat breeder and cat owner journals appeared assuming that obviously there is a rescue for FeLV-infected cats suffering from this deadly infection. The immunomodulator [Buttner, M., 1993. Comp. Immun. Microbiol. Infect. Dis. 18, 1-10] used in those studies was the so-called 'paramunity inducer' PIND-ORF (Baypamun, Bayer, Leverkusen, Germany) consisting of inactivated parapox ovis virus. Since that time, Baypamun is the most commonly used drug for treatment of FeLV infection in Germany and other European countries. Four placebo-controlled double-blind trials were performed to determine the therapeutic efficacy of Baypamun and other compounds in naturally FeLV-infected cats under controlled conditions.

• Authors: K Hartmann, A Block, G Ferk, B Beer, A Vollmar, H Lutz
• Journal: Veterinary microbiology (Vet Microbiol) Vol. 69 Issue 1-2 Pg. 111-3 (Sep 01 1999) ISSN: 0378-1135 [Print] Netherlands
• PMID: 10515279 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Adjuvants, Immunologic
• Antiviral Agents
• Baypamun HK
• Viral Vaccines
• Zidovudine

Topics

• Adjuvants, Immunologic (therapeutic use)
• Animals
• Antiviral Agents (therapeutic use)
• Cats
• Feline Acquired Immunodeficiency Syndrome (drug therapy)
• Leukemia Virus, Feline
• Viral Vaccines (therapeutic use)
• Zidovudine (therapeutic use)